Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

Summary

The purpose of the study is to evaluate the safety and tolerability of BNA035 in order to determine the maximum tolerated dose (MTD) and Recommended Phase 2 dose (RP2D) and to evaluate the preliminary efficacy for each combination regimen.

Timeline

Start

2022-02-08

Primary completion

2023-11

Completion

2025-11

Drugs

Indications